Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study

Ben Van Calster(University Medical Center Utrecht), S. Guerriero(University of Cagliari), A. C. Testa(Università Cattolica del Sacro Cuore), E. Epstein(Karolinska Institutet), D. Fischerová(Charles University), T. Bourne(Luigi Sacco Hospital), L. Savelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Chiara Lanzani(University of Milan), L. Valentin(Malmö University), Felice Scala(Cornell University), Robert Fruscio(Azienda Ospedaliera San Gerardo), D. Franchi(European Institute of Oncology), Artur Czekierdowski(Medical University of Lublin), J. Kaijser(KU Leuven), Kirsten Van Hoorde(iMinds), V. Van Belle(iMinds), D. Timmerman(Rega Institute for Medical Research), C. Van Holsbeke(Ziekenhuis Oost-Limburg)
BMJ
October 15, 2014
Cited by 500


Related Papers